Healthcare (PRC Firms)
Greater China Region Guide 2024 : China
Band 2
Email address
[email protected]Contact number
+9714 313 1700About
Provided by King & Wood Mallesons
Effective advice built on strong foundations
Healthcare and pharmaceutical companies come to us not only because we have deep expertise and the best people, but also because we bring industry knowledge to our practice.
With technological advances, ever-changing government regulations, and strict ethical considerations, it is clear that understanding legislation in the healthcare industry is no simple matter. We therefore seek to base our legal advice on a comprehensive understanding of today's industry developments. We keep abreast of legal and commercial developments in the pharmaceutical industry and host seminars for our clients to stay on the cutting edge of the industry together.
We provide legal advice to clients in the pharmaceutical and healthcare industries in areas such as intellectual property, regulation, business, competition and corporate law. With strong support from our offices throughout China and Australia, our clients can benefit from our local expertise where need it most. We know that sometimes clients need to close a deal or respond to a question quickly, so we focus on making sure the clients get straight and clear answers quickly.
Chambers Review
King & Wood Mallesons has a prominent healthcare and pharmaceuticals team which advises an impressive client base of international and local investors in the industry. The team is well experienced in handling corporate, investment, capital market and IP matters as well as regulatory and licensing matters, and is especially skilled in cross-border transactions. It acts for clients from sectors including pharmaceuticals, biotechnology, health insurance and medical service providers, such as Boehringer Ingelheim, Shanghai Brighten Optix Vision Technology and Mega Genomics. The law firm offers expertise in contentious matters in the healthcare space, notably in relation to IP infringements and corporate investigation issues.
金杜律师事务所拥有一支杰出的医疗保健和制药团队，在医疗领域里持续为令人刮目相看的国际和本地投资者客户群提供建议。该团队处理公司、投资、资本市场、知识产权及合规事宜经验丰富，尤其擅长处理跨境交易。其代表各行业客户，包括制药、生物技术、医疗保险和医疗服务供应商如勃林格殷格翰，上海亨泰视觉科技及美因基因。金杜就医事法领域内的争议性事务提供专业知识， 特别是有关知识产权侵权和公司调查的案件。
Work Highlights
- King & Wood Mallesons advised Idorsia on its licensing deal with Simcere concerning the commercialisation of a new insomnia drug.
- 金杜律师事务所代表Idorsia处理其与先声药业的授权协议，该协议有关其新的失眠药物的商业化。
Strengths
Provided by Chambers
"KWM are highly dedicated, and their responsiveness is exceptional. They always deliver high-quality and efficient services within the timeframes we specify, even under tight schedules."
"King & Wood Mallesons offers quick responses, detailed analysis and feasible suggestions."
“金杜律师非常敬业，而且反馈速度非常出色。即使时间紧迫，他们也总是在我们指定的时间内提供高质量和高效的服务。”
“金杜团队反馈迅速，能够提供详细的分析和可行的建议。”
"KWM are highly dedicated, and their responsiveness is exceptional. They always deliver high-quality and efficient services within the timeframes we specify, even under tight schedules."
"King & Wood Mallesons offers quick responses, detailed analysis and feasible suggestions."
“金杜律师非常敬业，而且反馈速度非常出色。即使时间紧迫，他们也总是在我们指定的时间内提供高质量和高效的服务。”
“金杜团队反馈迅速，能够提供详细的分析和可行的建议。”
Notable Practitioners
Mark Zhang is building up his practice in the healthcare space by frequently assisting companies and medical institutions with foreign investment, licensing and compliance matters. He operates out of the firm's Shanghai office.
张运帷律师透过经常协助公司和医疗机构进行国外投资、重组以及合规和调查事宜，正在医疗保健领域建立其业务。他在该所的上海办公室工作。